CHEMED CORPORATION Revenue from Contract with Customer, Including Assessed Tax
CHEMED CORPORATION (CHE) reported Revenue from Contract with Customer, Including Assessed Tax of $1.57 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2025-02-28
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for the quarter ending 2024-12-31 was $420.82M, a 17.40% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for the quarter ending 2024-09-30 was $399.15M, a 17.12% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for the quarter ending 2024-06-30 was $382.91M, a 16.12% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for the quarter ending 2024-03-31 was $363.42M, a 13.89% increase year-over-year.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for fiscal 2024 was $1.57B, a 16.18% increase from fiscal 2023.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for fiscal 2023 was $1.35B, a 9.51% increase from fiscal 2022.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for fiscal 2022 was $1.23B, a 4.53% decline from fiscal 2021.
- CHEMED CORPORATION revenue from contract with customer, including assessed tax for fiscal 2021 was $1.29B, a 5.78% decline from fiscal 2020.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | $420.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $819.97M derived: sum of 2 quarters · filed 2025-02-28 | $1.20B derived: sum of 3 quarters · filed 2025-02-28 | $1.57B 10-K · filed 2025-02-28 |
| 2024-09-30 | $399.15M 10-Q · filed 2024-11-01 | $782.06M derived: sum of 2 quarters · filed 2024-11-01 | $1.15B 10-Q · filed 2024-11-01 | $1.50B derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | $382.91M 10-Q · filed 2024-07-26 | $746.33M 10-Q · filed 2024-07-26 | $1.10B derived: sum of 3 quarters · filed 2025-02-28 | $1.45B derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | $363.42M 10-Q · filed 2024-04-29 | $721.87M derived: sum of 2 quarters · filed 2025-02-28 | $1.06B derived: sum of 3 quarters · filed 2025-02-28 | $1.39B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $358.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $699.25M derived: sum of 2 quarters · filed 2025-02-28 | $1.03B derived: sum of 3 quarters · filed 2025-02-28 | $1.35B 10-K · filed 2025-02-28 |
| 2023-09-30 | $340.80M 10-Q · filed 2024-11-01 | $670.55M derived: sum of 2 quarters · filed 2024-11-01 | $989.66M 10-Q · filed 2024-11-01 | $1.31B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $329.75M 10-Q · filed 2024-07-26 | $648.86M 10-Q · filed 2024-07-26 | $965.46M derived: sum of 3 quarters · filed 2025-02-28 | $1.27B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $319.11M 10-Q · filed 2024-04-29 | $635.70M derived: sum of 2 quarters · filed 2025-02-28 | $938.32M derived: sum of 3 quarters · filed 2025-02-28 | $1.24B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $316.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $619.22M derived: sum of 2 quarters · filed 2025-02-28 | $924.22M derived: sum of 3 quarters · filed 2025-02-28 | $1.23B 10-K · filed 2025-02-28 |
| 2022-09-30 | $302.62M 10-Q · filed 2023-10-27 | $607.62M derived: sum of 2 quarters · filed 2023-10-27 | $914.41M 10-Q · filed 2023-10-27 | $1.24B derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $305.00M 10-Q · filed 2023-07-28 | $611.79M 10-Q · filed 2023-07-28 | $935.61M derived: sum of 3 quarters · filed 2024-02-29 | $1.26B derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $306.79M 10-Q · filed 2023-04-28 | $630.61M derived: sum of 2 quarters · filed 2024-02-29 | $953.37M derived: sum of 3 quarters · filed 2024-02-29 | $1.27B derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $323.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $646.58M derived: sum of 2 quarters · filed 2024-02-29 | $966.24M derived: sum of 3 quarters · filed 2024-02-29 | $1.29B 10-K · filed 2024-02-29 |
| 2021-09-30 | $322.76M 10-Q · filed 2022-11-02 | $642.41M derived: sum of 2 quarters · filed 2022-11-02 | $965.61M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $319.66M 10-Q · filed 2022-07-29 | $642.85M 10-Q · filed 2022-07-29 | ||
| 2021-03-31 | $323.20M 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | $1.37B 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $1.32B 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $1.22B 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |